SMTL ID : 2v7a.1 (1 other biounit)

Crystal structure of the T315I Abl mutant in complex with the inhibitor PHA-739358

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

monomer

Ligands

1 x 627: N-[(3E)-5-[(2R)-2-METHOXY-2-PHENYLACETYL]PYRROLO[3,4-C]PYRAZOL-3(5H)-YLIDENE]-4-(4-METHYLPIPERAZIN-1-YL)BENZAMIDE(Non-covalent)

627.1: 14 residues within 4Å: Chain A: L.22, G.24, A.43, K.45, E.90, F.91, M.92, T.93, Y.94, G.95, R.141, N.142, L.144, A.154 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:A.43, A:F.91, A:L.144, A:L.144, A:A.154 Hydrogen bonds: A:E.90, A:M.92, A:M.92

1 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 2 residues within 4Å: Chain A: N.142, D.155 2 PLIP interactions: 1 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:D.155, H2O.3

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Modugno, M. et al., Crystal Structure of the T315I Abl Mutant in Complex with the Aurora Kinases Inhibitor Pha-739358. Cancer Res. (2007)

Release Date

2007-09-18

Peptides

PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1

Related Entries With Identical Sequence